Products - Clinical Studies - Why Regenesis

Pro 800 - Pro 500 - Deer Antler Velvet - Slumber Spray


For more information on growth hormone and Regenesis Pro products, including graphs for this study go to Information for Health Care Professionals (Adobe Acrobat Format). Graphs are on pages 24-25.


Babak Parisan M.D. of the Bushard Medical Group clinically evaluated and assisted in a six-month study involving the administration of a polymer matrix oral spray Recombinant Growth Hormone delivery system. 200 healthy patients were screened and tested (112 females and 88 males). IGF-1 testing is presently the standard accepted protocol for evaluating the level of Growth Hormone in the blood.

Patients were pre-examined to determine a baseline IGF-1: 114.26 ng/ml in females (average age 51) and 135.22 ng/ml in males (average age 48). No change in diet was advised, however it was noted that all patients ate an average of 3 meals per day with approximately 3000 calories.

Testing began with a prescribed dosage of 3 sprays in the morning within one hour of awakening (equaling approximately 1000 ng of HGH) and 3 sprays in the evening immediately before retiring (totaling approximately 2000 ng of GH per day, seven days a week).

30 days after inception, testing showed that patients' IGF-1 levels were elevated 30% over baselines: 149.85 ng/ml in females and 176.31 ng/ml in males.

After 60 days, IGF-1 levels were tested again and shown to be 53% over baselines: 175.63 ng/ml in females and 209.59 ng/ml in males. At the end of the 6 month study, IGF-1 levels had increased over 102% over baseline in females (232.12 ng/ml) and 109% over baseline in males (284.05 ng/ml).

Cholesterol levels were diminished in 94 patients by an average of 14.8%, and triglyceride levels were also reduced by 31%. Improvements were noted in mental stability, muscle accretion, weight reduction, energy level, libido, epidermis rejuvenation, and reacquired hair color and density. In all 200 patients no adverse side effects were reported or observed.

Results indicate the following: The study suggests that the use of the 191 amino acid growth hormone molecule administered in a sublingual application is an effective method for encouraging and promoting the rejuvenation of cellular tissues.


Disclaimer: Regenesis makes no medical claims - Statements contained herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
The information is for educational use only. Do not attempt to self-diagnose or treat any condition. Please consult your healthcare practitioner if you believe you may have any of the signs or symptoms discussed above before using any of the nutrients discussed.
You should also consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.
Always read and follow all label directions.